Mode
Text Size
Log in / Sign up
N/A N=31 Prevention

Technology Based Sedentary Reduction Intervention in Patients With Type 2 Diabetes

Type 2 Diabetes · Sedentary Behavior · Physical Activity

Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Level of Satisfaction With the Intervention Assessed by Lyons et al and Burner et al.'s Questionnaires — 5; 4; 5; 4 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Sit Less Program (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Vanderbilt University
Primary completion
Jan 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Level of Satisfaction With the Intervention Assessed by Lyons et al and Burner et al.'s Questionnaires
5; 4; 5; 4; 5; 5
PRIMARY
Level of Compliance With the Intervention Assessed by Number of Days the Fitbit Device Was Worn
6.58; 6.13
PRIMARY
Changes of Total Daily Sedentary Time
622.5488; 670.8750; 640.7781; 554.6351; 602.8750; 609.5371 0.578
PRIMARY
Changes of Prolonged Sedentary Time
262.978375; 226.240200; 187.086785; 198.121663; 147.582360; 165.056000 0.61
PRIMARY
Changes of Sit-to-stand Transitions
31.25; 42.80; 46.08; 32.75; 43.20; 45.31 0.674
SECONDARY
Changes of Physical Activity Measured by 7 Days of activPAL Device Monitoring
37.547425; 63.195200; 67.806546; 54.1757038; 75.4577200; 75.1487769 .013 sig
SECONDARY
Changes of Confidence in Reducing Sedentary Behavior Measured by Using 6 Items From the Self-Efficacy Questionnaire for Physical Activity and Sedentary Behavior.
3.9038; 3.7000; 3.9038; 3.3750; 3.8500; 3.3846 0.29
SECONDARY
Changes of Habit Strength for Sedentary Behavior Assessed by Using the Self-Report Habit Index.
6.2143; 6.0857; 5.2967; 5.8214; 5.5143; 5.8462 0.701
SECONDARY
Changes of 24-hour Mean Glucose Levels Assessed by Continuous Glucose Monitors
120.7143; 135.2500; 129.3846; 126.0000; 115.7500; 153.5385 0.376

Summary

The purpose of this study is to develop and test an 8-week sedentary behavior reduction intervention ("Sit Less" program) for patients with type 2 diabetes. The program aims to reduce and break sitting times among this population using an objective activity monitor and mHealth. The investigators will test the program to help diabetes patients break up sitting time, reduce daily sitting time, and move more. The investigators will also study preliminary effects of the SB reduction intervention on light physical activity, cardiometabolic markers and patient-centered outcomes, and whether diabetes patients like the program and can follow it.

Eligibility Criteria

Inclusion Criteria

  • ages 18 and above
  • diagnosed with type 2 diabetes
  • self-reported HbA1C 300
  • currently participating in exercise or other research programs
  • non-English speaking
  • patients who are classified as unstable (e.g. heart failure, uncontrolled arrhythmia) or have kidney disease that limits daily water intake, or any other conditions contradictory to standing or walking
  • currently pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05691452). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search